|
Bredell, Helba; Martin, Darren P; Van Harmelen, Joanne et al. (2007) HIV type 1 subtype C gag and nef diversity in Southern Africa. AIDS Res Hum Retroviruses 23:477-81
|
|
Rademeyer, Cecilia; Moore, Penny L; Taylor, Natasha et al. (2007) Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies. Virology 368:172-81
|
|
Gray, Clive M; Williamson, Carolyn; Bredell, Helba et al. (2005) Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. AIDS Res Hum Retroviruses 21:285-91
|
|
de Bruyn, Guy; Hudgens, Michael G; Sullivan, Patrick S et al. (2005) Participant retention in clinical trials of candidate HIV vaccines. J Acquir Immune Defic Syndr 39:499-501
|
|
Masemola, Agatha M; Mashishi, Tumelo N; Khoury, Greg et al. (2004) Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol 173:4607-17
|
|
Masemola, Agatha; Mashishi, Tumelo; Khoury, Greg et al. (2004) Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol 78:3233-43
|
|
Lee, Deborah; Graham, Barney S; Chiu, Ya-Lin et al. (2004) Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. J Infect Dis 190:903-7
|
|
Gouws, Eleanor; Williams, Brian G; Sheppard, Haynes W et al. (2002) High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr 29:531-5
|
|
Colfax, Grant N; Buchbinder, Susan P; Cornelisse, Peter G A et al. (2002) Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS 16:1529-35
|
|
Sheppard, Haynes W; Celum, Connie; Michael, Nelson L et al. (2002) HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr 29:307-13
|
Showing the most recent 10 out of 12 publications
